Main > A1. CORP. INDEX. Ln-Lz > Lundbeck/P C2
This data is not available for free
Lundbeck/P C2's subsections
2000. 06.19.2000. (Depression)
2000. 06.19.2000. (Executive)
2001. 10.01.2001. (Depression)
2002. 11.25.2002. (Parent of)
2002. 12.02.2002. (Depression)
2004. 02.16.2004. (Insomnia)
2009. 02.16.2009. (CEO)
2011. 11.11.2011. Otsuka Pharma.
2012. 08.28.2012. Onco.>CLL & iNHL
2013. 03.20.2013. Neuro.>PD
2013. 07.17. Neuro.>AD
2013. 08.12. Neuro.>LGS
2013. 09.30. ReOrg...
2013. 10.31. Alcohol Dep.
2013. 11.21. Neuro.>Schizo.
2014. 01.21. Neuro.>MDD
2014. 03.10. Neuro.>Epilepsy
2014. 05.08. Acq. Chelsea Therap.
2018. 01.05. Schizophrenia
2018. 03.16. Acq. Prexton Ther PD
2019. 01.09. AI Numerate
2019. 05.06. Acq. Abide Therapeutic
2019. 09.16. Acq. Alder Biopharma.
2020. 02.22. Migraine USA>OK
2020. 04.06. Migraine USA>Launch
2021. 01.12. Migraine CA>OK
2023. 04.27. FDA Approves
Lundbeck Canada Inc. C2
Lundbeck Inc C2
Web-Site
Z - OK
Lundbeck/P C2's products
This section has no products